DTIL (STOCKS)
Precision BioSciences, Inc. Common Stock
$4.025000
-0.045000 (-1.11%)
Prev close: $4.070000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael Amoroso
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $96.89M
- Employees
- 67
- P/E (TTM)
- -0.48
- P/B (TTM)
- 2.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.84 | $-1.37 | -0.4732 | -34.62% |
|
Jun 2025 (Q2)
|
$-2.13 | $-1.60 | -0.5320 | -33.29% |
|
Mar 2025 (Q1)
|
$-2.21 | $-1.75 | -0.4590 | -26.21% |
|
Dec 2024 (Q4)
|
$-2.22 | $-2.00 | -0.2174 | -10.86% |
Financial Statements
| Revenues | $698.00K |
| Benefits Costs and Expenses | $84.30M |
| Costs And Expenses | $84.30M |
| Operating Expenses | $90.20M |
| Depreciation and Amortization | $1.58M |
| Research and Development | $55.62M |
| Other Operating Expenses | $33.01M |
| Operating Income/Loss | -$89.50M |
| Income/Loss Before Equity Method Investments | -$82.72M |
| Income/Loss From Continuing Operations After Tax | -$83.60M |
| Income/Loss From Continuing Operations Before Tax | -$83.60M |
| Income/Loss From Equity Method Investments | -$886.00K |
| Net Income/Loss | -$83.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$83.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$83.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$8.96 |
| Diluted Earnings Per Share | -$8.88 |
| Basic Average Shares | 11,119,806 |
| Diluted Average Shares | 11,021,225 |
| Assets | $93.51M |
| Current Assets | $51.71M |
| Prepaid Expenses | $5.86M |
| Other Current Assets | $45.85M |
| Noncurrent Assets | $41.81M |
| Fixed Assets | $2.03M |
| Intangible Assets | $985.00K |
| Other Non-current Assets | $38.79M |
| Liabilities | $76.88M |
| Current Liabilities | $15.00M |
| Accounts Payable | $1.34M |
| Wages | $3.16M |
| Other Current Liabilities | $10.50M |
| Noncurrent Liabilities | $61.88M |
| Equity | $16.63M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $16.63M |
| Liabilities And Equity | $93.51M |
| Net Cash Flow From Operating Activities | -$73.28M |
| Net Cash Flow From Operating Activities, Continuing | -$73.28M |
| Net Cash Flow From Investing Activities | -$406.00K |
| Net Cash Flow From Investing Activities, Continuing | -$406.00K |
| Net Cash Flow From Financing Activities | $23.57M |
| Net Cash Flow From Financing Activities, Continuing | $23.57M |
| Net Cash Flow | -$50.12M |
| Net Cash Flow, Continuing | -$50.12M |
| Comprehensive Income/Loss | -$83.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$83.60M |
| Other Comprehensive Income/Loss | $0.00 |